reference/30430572

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30430572

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1471-2407
issueIdentifier	1
pageRange	96-
publicationName	BMC Cancer
startingPage	96
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6db4b66f24c97794bcf54f5e7df37248 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_77f04db294a462f58d108aec7863673f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c8584d63accaf077547dfe88fee63d4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_19acaebcc0289dc40a95ec6351788922 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bffee15db8d52844fa8d63e9f0bf1654 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3b35727c0bc3418c7df7b004d06ee4ed
bibliographicCitation	Zhao ZM, Yost SE, Hutchinson KE, Li SM, Yuan YC, Noorbakhsh J, Liu Z, Warden C, Johnson RM, Wu X, Chuang JH, Yuan Y. CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer. BMC Cancer. 2019 Jan 21;19(1):96. PMID: 30665374; PMCID: PMC6341717.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6759513d8b483e7f6966602bc88cb61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06fc04cc249a25849663c72de9ebdd23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f66013ba226828e25e4758ee29d74cff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ea0039db1c8085ac8a6b3fd7597d7e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_debefd6ad9518dcc033552719aec7af8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e6c0cec10d2f39f023e4a053b763e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf5db983d586c3c0f21e37bb3f4ccde0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_194ab754867a2402ab26e4771e4029c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bae5db7a85d6c7f2e77d750b658cae92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b7cfd00c5e4467d99853f492078ac23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f57da28c100b7b281e1e120991c3165 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_371ec0c354cf0aa909cb380e6f80e59f
date	2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/30665374 https://doi.org/10.1186/s12885-019-5290-4 https://pubmed.ncbi.nlm.nih.gov/PMC6341717
isPartOf	https://portal.issn.org/resource/ISSN/1471-2407 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0451993 http://id.nlm.nih.gov/mesh/M0029602 http://id.nlm.nih.gov/mesh/M0023873
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8369f7c690795caa54317214d5efb891 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b9dfc2d3341369e2565197a07f91fc1e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eb68ffb956a9926a9e73fc09911fb509 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ade4bfa832d1adba9ab5c7dfb70e4d0b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b357466706b017dc04024546defa4da http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6cbf2d31b07ace69ae4891e27b08145c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a9c6637dc187d6eba8d873d07944d07e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID898

Total number of triples: 57.